David W Osborne - Net Worth and Insider Trading

David W Osborne Net Worth

The estimated net worth of David W Osborne is at least $4 Million dollars as of 2025-07-15. David W Osborne is the Chief Technical Officer of Arcutis Biotherapeutics Inc and owns about 268,854 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $4 Million. Details can be seen in David W Osborne's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David W Osborne has not made any transactions after 2023-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of David W Osborne

To

David W Osborne Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David W Osborne owns 1 companies in total, including Arcutis Biotherapeutics Inc (ARQT) .

Click here to see the complete history of David W Osborne’s form 4 insider trades.

Insider Ownership Summary of David W Osborne

Ticker Company Transaction Date Type of Owner
ARQT Arcutis Biotherapeutics Inc 2023-03-06 Chief Technical Officer

David W Osborne Latest Holdings Summary

David W Osborne currently owns a total of 1 stock. David W Osborne owns 268,854 shares of Arcutis Biotherapeutics Inc (ARQT) as of March 6, 2023, with a value of $4 Million.

Latest Holdings of David W Osborne

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARQT Arcutis Biotherapeutics Inc 2023-03-06 268,854 15.90 4,274,779

Holding Weightings of David W Osborne


David W Osborne Form 4 Trading Tracker

According to the SEC Form 4 filings, David W Osborne has made a total of 8 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 690 shares on March 6, 2023, which brought David W Osborne around $10,529.

Insider Trading History of David W Osborne

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David W Osborne Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David W Osborne Ownership Network

Ownership Network List of David W Osborne

No Data

Ownership Network Relation of David W Osborne

Insider Network Chart


David W Osborne Owned Company Details

What does Arcutis Biotherapeutics Inc do?

Who are the key executives at Arcutis Biotherapeutics Inc?

David W Osborne is the Chief Technical Officer of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include See Remarks Patrick Burnett , director & 10 percent owner Patrick J Heron , and SVP and General Counsel Masaru Matsuda .

Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary

Over the past 18 months, David W Osborne made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 317,114 shares made by Patrick Burnett , a net sale of 129,347 shares made by Howard G. Welgus , and a net sale of 129,106 shares made by Todd Franklin Watanabe .

In summary, during the past 3 months, insiders sold 90,294 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 27,448 shares, with a net sale of 62,846 shares. During the past 18 months, 681,648 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 61,288 shares were bought by its insiders, resulting in a net sale of 620,360 shares.

Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcutis Biotherapeutics Inc Insider Transactions

No Available Data

David W Osborne Mailing Address

Above is the net worth, insider trading, and ownership report for David W Osborne. Currently GuruFocus does not have mailing address information for David W Osborne.